Risk of thromboembolism in cancer patients with Port-a-Cath. Results and implications of the ONCOCIP study
The normal experience of cancer patients who receive an implantable venous access device (Port-a-Cath) for chemotherapy...
Epidemiology
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer
Cancer is a well-known risk factor for the occurrence of venous thromboembolism. In contrast, little research has been...
Arterial thromboembolism can also be the first clinical manifestation of a neoplasm
Several studies showed that venous thrombosis can be the first clinical manifestation of an occult neoplasm. For this...
The management of cancer patients with hemostatic disorders (thrombosis and/or bleeding) faces many clinical challenges
The management of cancer patients with hemostatic disorders (thrombosis and/or bleeding) faces many clinical...
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
The authors of a recent study1 have taken a novel look at the impact of venous thromboembolism (VTE) among...
Rational for new promising studies on occult cancer screening for patients with unprovoked venous thromboembolism
Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, can be the first sign of an...